ARTICLE | Company News
Kadmon, Valeant Pharmaceuticals sales and marketing update
March 3, 2014 8:00 AM UTC
Valeant's Valeant Pharmaceuticals North America LLC subsidiary granted Kadmon's Kadmon Pharmaceuticals LLC subsidiary U.S. co-commercialization rights to Syprine trientine capsules. The chelating comp...